PRTA Reports Initiation Of NEOD001 Global Phase 3; KERX Offers Phase 2 Trial Results For Auryxia
December 03, 2014 at 03:20 AM EST
PRTA announced the initiation of the VITAL Amyloidosis Study. KERX announced the publication of Auryxia phase 2 clinical trial results.
